La Roche-Posay's new Hyalu B5 Suractivated Cream is an advanced formula designed to bring the "bounce" back to skin by enhancing plumpness and hydration.
To complement the launch of the Hyalu B5 Suractivated Cream, La Roche-Posay upgraded its iconic Hyalu B5 Serum formula to include a 4 hyaluronic acid system to deliver 27 times more hyaluronic acid 8 layers into the skin. And as GLP-1 weight-loss medications create new skincare challenges—like visible facial volume loss and a lack of hydration—La Roche-Posay conducted a targeted consumer study on the Hyalu B5 Serum and Cream regimen. As the brand detailed in a press release, "after four weeks, 94% of participants felt the Hyalu B5 regimen effectively addressed their skin concerns since using GLP-1. 90% saw smoother, firmer and more radiant skin."
What Makes This Trend Stand Out
- Multi-modal Hyaluronic Systems
- Layered hyaluronic acid formulations combining multiple molecular weights enable deeper, varied hydration and volumizing effects that address structural skin deficits.
- Post-weight-loss Dermatology
- Rising use of GLP-1 medications has created a consumer cohort with distinct skin-volume and hydration needs, prompting demand for targeted dermatological solutions.
- Regimen-based Efficacy Proof
- Clinically backed multi-product regimens and short-term consumer studies are increasingly used to demonstrate measurable improvements and justify premium positioning.
Sectors Adopting This
- Skincare and Cosmeceuticals
- Advanced actives and delivery systems are opening opportunities for products that claim restorative volume and sustained hydration beyond basic moisturization.
- Aesthetic Medicine and Dermatology
- Providers and clinics are positioned to integrate topical regimens with injectables and procedures to address post-GLP-1 volume loss and skin texture concerns.
- Clinical Trials and Consumer Testing Services
- Specialized efficacy testing and targeted consumer studies are becoming a competitive differentiator for brands seeking evidence-based claims and market trust.
